相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid
Gunnar Brinkmalm et al.
JOURNAL OF MASS SPECTROMETRY (2012)
Cerebrospinal Fluid Profiles of Amyloid β-Related Biomarkers in Alzheimer's Disease
Christoffer Rosen et al.
NEUROMOLECULAR MEDICINE (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Cerebrospinal Fluid Levels of Soluble Amyloid Precursor Protein and β-Amyloid 42 in Patients with Multiple Sclerosis, Neuromyelitis Optica and Clinically Isolated Syndrome
W. Mai et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis
S. Rossi et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
A novel pathway for amyloid precursor protein processing
Erik Portelius et al.
NEUROBIOLOGY OF AGING (2011)
γ-Secretase-dependent amyloid-β is increased in Niemann-Pick type C A cross-sectional study
N. Mattsson et al.
NEUROLOGY (2011)
Cognitive and Cortical Plasticity Deficits Correlate with Altered Amyloid-β CSF Levels in Multiple Sclerosis
Francesco Mori et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Control of Local Protein Synthesis and Initial Events in Myelination by Action Potentials
Hiroaki Wake et al.
SCIENCE (2011)
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism
Niklas Mattsson et al.
BMC NEUROLOGY (2010)
Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain
Niklas Mattsson et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Cortical lesions and cognitive impairment in multiple sclerosis
F. Rinaldi et al.
NEUROLOGICAL SCIENCES (2010)
Amyloid and tau cerebrospinal fluid biomarkers in HIV infection
Magnus Gisslen et al.
BMC NEUROLOGY (2009)
Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis
N. Mattsson et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Multiple sclerosis and Alzheimer's disease
Assunta Dal Bianco et al.
ANNALS OF NEUROLOGY (2008)
Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo
John R. Cirrito et al.
NEURON (2008)
Characterization of amyloid ß peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry
Erik Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Orthogonal projections to latent structures as a strategy for microarray data normalization
Max Bylesjo et al.
BMC BIOINFORMATICS (2007)
Aspects of β-amyloid as a biomarker for Alzheimer's disease
Ulf Andreasson et al.
BIOMARKERS IN MEDICINE (2007)
Bace1 modulates myelination in the central and peripheral nervous system
Xiangyou Hu et al.
NATURE NEUROSCIENCE (2006)
Determination of β-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry
E Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Multiple sclerosis severity score -: Using disability and disease duration to rate disease severity
RHSR Roxburgh et al.
NEUROLOGY (2005)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
Multiple sclerosis diagnostic criteria: three years later
CH Polman et al.
MULTIPLE SCLEROSIS (2005)
Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus
E Trysberg et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Low cerebrospinal fluid β-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment
M Sjögren et al.
NEUROSCIENCE LETTERS (2001)